drosana 20 0.02 mg - 3 mg film-coat. tabl.
gedeon richter plc - drospirenone 3 mg; ethinylestradiol 0,02 mg - film-coated tablet - 0,02 mg - 3 mg - ethinylestradiol 0.02 mg; drospirenone 3 mg - drospirenone and ethinylestradiol
margotviatris 20 0.02 mg - 3 mg film-coat. tabl.
viatris gx bv-srl - ethinylestradiol 0,02 mg; drospirenone 3 mg - film-coated tablet - 0,02 mg - 3 mg - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and ethinylestradiol
perynella 0.02 mg - 3 mg film-coat. tabl.
exeltis germany gmbh - ethinylestradiol 0,02 mg; drospirenone 3 mg - film-coated tablet - 0,02 mg - 3 mg - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and ethinylestradiol
yadere 0.02 mg - 3 mg film-coat. tabl.
theramex ireland ltd. - drospirenone 3 mg (pink tablet); ethinylestradiol 0,02 mg (pink tablet); placebo (white tablet) - film-coated tablet - 0,02 mg - 3 mg - ethinylestradiol 0.02 mg; drospirenone 3 mg; placebo - drospirenone and ethinylestradiol
drospirenone and ethinyl estradiol tablets
mylan pharmaceuticals ulc - drospirenone; ethinyl estradiol - tablet - 3mg; 0.02mg - drospirenone 3mg; ethinyl estradiol 0.02mg - contraceptives
ethinylestradiol / drospirenone leon farma & placebo 0.03 mg/ 3 mg film-coated tablets
laboratorios leon farma, s.a. - drospirenone; ethinylestradiol - film-coated tablet - 0.03 mg/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol
lucette 0.03mg/3mg tablets
gedeon richter (uk) ltd - drospirenone; ethinylestradiol - oral tablet - 3mg ; 30microgram
nextstellis estetrol (as monohydrate) 14.2 mg / drospirenone 3 mg tablet blister pack
mayne pharma international pty ltd - estetrol monohydrate, quantity: 15 mg (equivalent: estetrol, qty 14.2 mg); drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: magnesium stearate; titanium dioxide; hypromellose; hyprolose; purified talc; hydrogenated cottonseed oil; lactose monohydrate; maize starch - nextstellis is indicated for use by women of reproductive potential to prevent pregnancy.
vestura- drospirenone and ethinyl estradiol
actavis pharma, inc. - drospirenone (unii: n295j34a25) (drospirenone - unii:n295j34a25), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - drospirenone 3 mg - vestura is indicated for use by women to prevent pregnancy. vestura is also indicated for the treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who choose to use an oral contraceptive as their method of contraception. the effectiveness of vestura for pmdd when used for more than three menstrual cycles has not been evaluated. the essential features of pmdd according to the diagnostic and statistical manual-4th edition (dsm-iv) include markedly depressed mood, anxiety or tension, affective lability, and persistent anger or irritability. other features include decreased interest in usual activities, difficulty concentrating, lack of energy, change in appetite or sleep, and feeling out of control. physical symptoms associated with pmdd include breast tenderness, headache, joint and muscle pain, bloating and weight gain. in this disorder, these symptoms occur regularly during the luteal phase and remit within a few days following onset of menses; the disturbance markedly interferes with work
myelle 0.02 mg/3 mg tablets
mcdermott laboratories ltd t/a gerard laboratories - drospirenone; ethinylestradiol - tablet - 0.02mg/3 milligram(s) - drospirenone and ethinylestradiol